Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a potential target for development of novel antibiotics | Staphylococcus aureus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(5-bromo-2-hydroxyphenyl)([(E)-[1-(1-methyl-1H-indol-2-yl)ethylidene]amino]oxy)methanone | 34% inhibition at 0.01 mM | Staphylococcus aureus | |
(5-bromo-2-methoxyphenyl)([(E)-[1-(1-methyl-1H-indol-2-yl)ethylidene]amino]oxy)methanone | 33% inhibition at 0.01 mM | Staphylococcus aureus | |
(E)-5-bromo-2-hydroxy-N'-(1-(4,5,6-trifluoro-1Hindol-2-yl)ethylidene)benzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-2-hydroxy-N'-(1-(5-hydroxy-1H-indol-2-yl)ethylidene)benzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-2-hydroxy-N'-(1-(5-methoxy-1H-indol-2-yl)ethylidene)benzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(4,5-difluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(5,6-difluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(5-bromo-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(5-bromo-1H-indol-2-yl)propylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(5-chloro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(5-fluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(6-bromo-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-5-bromo-N'-(1-(7-fluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | 39% inhibition at 500 nM | Staphylococcus aureus | |
(E)-N'-((1H-indol-2-yl)methylene)-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-2-hydroxy-5-chlorobenzohydrazide | 36% inhibition at 0.001 mM | Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-2-hydroxy-5-iodobenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-3,5-dibromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-3,5-dibromo-2-methoxybenzohydrazide | 57% inhibition at 0.001 mM | Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-3-bromobenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-4-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-(prop-2-ynyloxy)benzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-hydroxy-4-methoxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-methoxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)benzohydrazide | 28% inhibition at 0.01 mM | Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)ethylidene)picolinohydrazid | 15% inhibition at 0.01 M | Staphylococcus aureus | |
(E)-N'-(1-(1H-indol-2-yl)propylidene)-5-bromo-2-hydroxybenzohydrazide | crystal structure determination of the inhibitor compound | Staphylococcus aureus | |
(E)-N'-[(1H-indol-2-yl)methylene]-5-bromo-2-methoxybenzohydrazide | - |
Staphylococcus aureus | |
(E)-N'-[1-(1H-indol-2-yl)ethylidene]-2-hydroxy-3,5-diisopropylbenzohydrazide | 40% inhibition at 0.01 mM | Staphylococcus aureus | |
(E)-N'-[1-(1H-indol-2-yl)ethylidene]-5-bromo-2-ethoxybenzohydrazide | - |
Staphylococcus aureus | |
(E/Z)-N'-((1H-indol-2-yl)(phenyl)methylene)-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
(Z)-N'-(1-(1H-indol-2-yl)-2,2-dimethylpropylidene)-5-bromo-2-hydroxybenzohydrazide | crystal structure determination of the inhibitor compound | Staphylococcus aureus | |
2-hydroxy-5-iodo-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
2-[(1E)-1-[2-[(5-bromo-2-methoxyphenyl)(dioxido-l6-sulfanylidene)methyl]hydrazinylidene]ethyl]-1H-indole | 12% inhibition at 0.01 mM | Staphylococcus aureus | |
2-[(1E)-1-[2-[(5-bromo-2-methoxyphenyl)(dioxido-l6-sulfanylidene)methyl]hydrazinylidene]ethyl]-4,5-difluoro-1H-indole | 11% inhibition at 0.01 mM | Staphylococcus aureus | |
3-hydroxy-N'-[(1E)-1-(1H-indol-2-yl)ethylidene]naphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)ethylidene]naphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)propylidene]naphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1H-indol-2-yl)propylidene]naphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
4-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | 611% inhibition at 500 nM | Staphylococcus aureus | |
4-hydroxy-N'-[(1E)-1-(1H-indol-2-yl)ethylidene]-1,10-biphenyl-3-carbohydrazide | 20% inhibition at 0.01 mM | Staphylococcus aureus | |
5-bromo-2-(ethoxymethoxy)-N'-((1E)-1-(1H-indol-2-yl)ethylidene)benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-4-methoxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-benzimidazol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)propylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(5-hydroxy-1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(5-iodo-1H-indol-2-yl)ethylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-(5-methoxy-1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | 54% inhibition at 0.001 mM | Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(1E)-1-[5-(trifluoromethyl)-1Hindol-2-yl]ethylidene]benzohydrazide | 46% inhibition at 0.01 mM | Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(E)-(1-methyl-1H-indol-2-yl)(phenyl)methylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-2-hydroxy-N'-[(E)-(1-methyl-1H-indol-2-yl)methylidene]benzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(1H-indol-2-yl)ethylidene]-2-methoxy-N-methylbenzohydrazide | 33% inhibition at 0.001 mM | Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(4,5-difluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(5,6-difluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)propylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(5-chloro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(5-fluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
5-bromo-N'-[(1E)-1-(6-bromo-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
additional information | inhibitor development, synthesis, optimization, and structure-activity relationship analysis, inhibitor potencies in growth inhibition of strains RN4220, ATCC 25923, and ATCC 29213, overview. No inhibition by (E)-5-bromo-2-hydroxy-N'-(1-(5-phenyl-1H-indol-2-yl)ethylidene)benzohydrazide, (Z)-N'-(1-(1H-indol-2-yl)-2,2-dimethylpropylidene)-5-bromo-2-hydroxybenzohydrazide, and 5-bromo-N'-[(1E)-2,2-dimethyl-1-(1-methyl-1H-indol-2-yl)propylidene]-2-hydroxybenzohydrazide | Staphylococcus aureus | |
N'-[(1E)-1-(1,3-benzothiazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(1,3-benzoxazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | 26% inhibition at 500 nM | Staphylococcus aureus | |
N'-[(1E)-1-(1-benzothiophen-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(1H-benzimidazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)ethylidene]-3-hydroxynaphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)propylidene]-3-hydroxynaphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(5-bromo-1H-indol-2-yl)ethylidene]-3-hydroxynaphthalene-2-carbohydrazide | - |
Staphylococcus aureus | |
N'-[(1E)-1-(5-bromo-1H-indol-2-yl)propylidene]-3-hydroxynaphthalene-2-carbohydrazide | - |
Staphylococcus aureus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Staphylococcus aureus | - |
MRSA | - |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.000015 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-2-hydroxy-N'-(1-(4,5,6-trifluoro-1Hindol-2-yl)ethylidene)benzohydrazide | |
0.000017 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(6-bromo-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000018 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(5-bromo-1H-indol-2-yl)propylidene]-3-hydroxynaphthalene-2-carbohydrazide | |
0.00002 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(5,6-difluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000024 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(6-bromo-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000024 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(4,5-difluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000026 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(5-bromo-1H-indol-2-yl)ethylidene]-3-hydroxynaphthalene-2-carbohydrazide | |
0.000031 | - |
pH 7.5, 30°C | Staphylococcus aureus | 3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1H-indol-2-yl)propylidene]naphthalene-2-carbohydrazide | |
0.000042 | - |
pH 7.5, 30°C | Staphylococcus aureus | 3-hydroxy-N'-[(1E)-1-(1H-indol-2-yl)ethylidene]naphthalene-2-carbohydrazide | |
0.000043 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(5-iodo-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000049 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(5-fluoro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000049 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(5-bromo-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000049 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-[(1H-indol-2-yl)methylene]-5-bromo-2-methoxybenzohydrazide | |
0.000052 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(5-chloro-1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide | |
0.000052 | - |
pH 7.5, 30°C | Staphylococcus aureus | 3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)propylidene]naphthalene-2-carbohydrazide | |
0.000055 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000059 | - |
pH 7.5, 30°C | Staphylococcus aureus | 3-hydroxy-N'-[(1E)-1-(4,5,6-trifluoro-1-methyl-1H-indol-2-yl)ethylidene]naphthalene-2-carbohydrazide | |
0.000061 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(5,6-difluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000063 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-[1-(1H-indol-2-yl)ethylidene]-5-bromo-2-ethoxybenzohydrazide | |
0.000064 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-(prop-2-ynyloxy)benzohydrazide | |
0.000074 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-3,5-dibromo-2-hydroxybenzohydrazide | |
0.000079 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)propylidene]-3-hydroxynaphthalene-2-carbohydrazide | |
0.000085 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-hydroxybenzohydrazide | |
0.000091 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(1H-benzimidazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | |
0.000115 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)ethylidene]-3-hydroxynaphthalene-2-carbohydrazide | |
0.000126 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)propylidene)-5-bromo-2-hydroxybenzohydrazide | |
0.000145 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(4,5-difluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000146 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000151 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-2-hydroxy-5-iodobenzohydrazide | |
0.000165 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(5-fluoro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000168 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(5-bromo-1-methyl-1H-indol-2-yl)propylidene]-2-hydroxybenzohydrazide | |
0.000178 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-2-hydroxy-N'-(1-(5-methoxy-1H-indol-2-yl)ethylidene)benzohydrazide | |
0.000182 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-methoxybenzohydrazide | |
0.000214 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-2-hydroxy-N'-(1-(5-hydroxy-1H-indol-2-yl)ethylidene)benzohydrazide | |
0.000224 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(1,3-benzothiazol-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | |
0.000227 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-benzimidazol-2-yl)ethylidene]benzohydrazide | |
0.000228 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-N'-[(1E)-1-(5-chloro-1-methyl-1H-indol-2-yl)ethylidene]-2-hydroxybenzohydrazide | |
0.000251 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-(ethoxymethoxy)-N'-((1E)-1-(1H-indol-2-yl)ethylidene)benzohydrazide | |
0.000286 | - |
pH 7.5, 30°C | Staphylococcus aureus | N'-[(1E)-1-(1-benzothiophen-2-yl)ethylidene]-5-bromo-2-hydroxybenzohydrazide | |
0.000324 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-5-bromo-2-hydroxy-4-methoxybenzohydrazide | |
0.000381 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000445 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E/Z)-N'-((1H-indol-2-yl)(phenyl)methylene)-5-bromo-2-hydroxybenzohydrazide | |
0.000451 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-5-bromo-N'-(1-(5-bromo-1H-indol-2-yl)propylidene)-2-hydroxybenzohydrazide | |
0.000461 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)propylidene]benzohydrazide | |
0.000483 | - |
pH 7.5, 30°C | Staphylococcus aureus | 2-hydroxy-5-iodo-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000794 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(1E)-1-(5-methoxy-1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000841 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-4-methoxy-N'-[(1E)-1-(1-methyl-1H-indol-2-yl)ethylidene]benzohydrazide | |
0.000863 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-((1H-indol-2-yl)methylene)-5-bromo-2-hydroxybenzohydrazide | |
0.001312 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-4-bromo-2-hydroxybenzohydrazide | |
0.003087 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(E)-(1-methyl-1H-indol-2-yl)methylidene]benzohydrazide | |
0.006043 | - |
pH 7.5, 30°C | Staphylococcus aureus | 5-bromo-2-hydroxy-N'-[(E)-(1-methyl-1H-indol-2-yl)(phenyl)methylidene]benzohydrazide | |
0.00815 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-3-bromobenzohydrazide | |
0.008615 | - |
pH 7.5, 30°C | Staphylococcus aureus | (E)-N'-(1-(1H-indol-2-yl)ethylidene)-2-hydroxybenzohydrazide |